PLUS THERAPEUTICS, Inc. - Common Stock (PSTV)
1.2700
-0.3000 (-19.11%)
Plus Therapeutics Inc is a biotechnology company focused on developing innovative therapies for cancer treatment
The company utilizes a proprietary nanoscale particle technology aimed at delivering targeted, localized therapies to improve patient outcomes while minimizing systemic side effects. Their pipeline includes treatments designed to address various types of cancer, with a particular emphasis on rare and hard-to-treat indications. Through its research and development efforts, Plus Therapeutics is committed to advancing the science of cancer care and providing new options for patients facing challenging diagnoses.

Via Benzinga · March 10, 2025

Stay updated with the latest market activity on Friday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight.
Via Chartmill · March 7, 2025

Discover the stocks with unexpected trading volume in today's session on the US markets.
Via Chartmill · March 7, 2025

As we await the opening of the US market on Friday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via Chartmill · March 7, 2025

Plus Therapeutics stock rises after peer-reviewed publication of Phase 1 glioma data and FDA Orphan Drug Designation for lung cancer treatment.
Via Benzinga · March 7, 2025

Via Benzinga · March 7, 2025

The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Via Chartmill · March 6, 2025

U.S. stock futures rose on Friday following Thursday's selloff that pushed the Nasdaq 100 index into the correction zone.
Via Benzinga · March 7, 2025

Let's have a look at what is happening on the US markets one hour before the close of the markets on Thursday. Below you can find the top gainers and losers in today's session.
Via Chartmill · March 6, 2025

Thursday's session is buzzing with activity. Check out the stocks that are attracting the most attention and driving market activity!
Via Chartmill · March 6, 2025

Which stocks have an unusual volume on Thursday?
Via Chartmill · March 6, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · March 6, 2025

The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Via Chartmill · March 6, 2025

Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Via Chartmill · March 6, 2025

As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via Chartmill · March 5, 2025

Let's have a look at what is happening on the US markets on Wednesday. Below you can find the stocks with an unusual volume in today's session.
Via Chartmill · March 5, 2025

Via Benzinga · November 7, 2024

Via Benzinga · September 30, 2024

Via Benzinga · September 30, 2024

Via Benzinga · September 27, 2024

PSTV stock results show that Plus Therapeutics missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via InvestorPlace · August 14, 2024

PSTV stock results show that Plus Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via InvestorPlace · May 15, 2024

Plus Therapeutics will secure $3 million in funding from the Department of Defense for pediatric brain cancer trial expansion.
Via Benzinga · April 22, 2024